Xlife Sciences invests in Fuse-AI

Xlife Sciences invests in Fuse-AI

The Swiss company Xlife Sciences invests in the AI start-up Fuse-AI. Fuse-AI develops the ProstateCarcinoma.ai assistance system for the diagnosis of prostate cancer based on annotated MRI data using AI technology. 

169913 2019 Logo XLife siences RGB
Image: Xlife Sciences AG

The companies did not provide any details regarding the financial details of the agreement and the amount of the investment.